Evidence map›Paper›PMID 36459268›Full record

ArticleMolecular and cellular biochemistry2023

CircPACRGL promoted cell proliferation, migration and invasion as well as inhibited cell apoptosis in colorectal cancer via regulation of the miR-330-3p/CNBP axis.

Haiyun Liu, Yongqing Fang, Benchao Hou, Qianxia Lin, Wenchun Zhang, Xiaomin Wang, Yuan Hu, Guoliang Xu, Zhijian He

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Role of Oxysterol-Binding Protein Family in Cholesterol Metabolism and Cancer Progression: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  2. CircARID1B Promotes MPPCell biochemistry and biophysics · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Haiyun Liu *College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Yongqing Fang *College of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Benchao HouDepartment of Anesthesiology, The First Affiliated Hospital of Nanchang University, No.17 Yongwaizheng Avenue, Donghu District, Nanchang, 330006, Jiangxi, China.
Qianxia LinCollege of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Wenchun ZhangCollege of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Xiaomin WangCollege of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Yuan HuSchool of Inter-Cultural Studies, Jiangxi Normal University, Nanchang, Jiangxi, China.
Guoliang XuResearch Center for Differentiation and Development of Traditional Chinese Medicine (TCM) Basic Theory, Jiangxi University of Chinese Medicine, No.1688 Meiling Avenue, Nanchang, 330004, Jiangxi, China. lhy98175@163.com.
Zhijian HeDepartment of Radiation Oncology, Jiangxi Cancer Hospital, NO.519 East Beijing Road Street, Nanchang, Jiangxi, China. jxncga@126.com.ORCID http://orcid.org/0000-0001-6708-6169
Jiangxi University of Traditional Chinese Medicine · CNJiangxi Normal University · CNJiangxi Provincial Cancer Hospital · CNNanchang University · CN

Funding

2019 University-level Innovation and Entrepreneurship Training Plan for College Students of Jiangxi University of Chinese Medicine 201910412045Double first-class discipline construction in Jiangxi Province JXSYLXK-ZHY1054Science and Technology Project of Jiangxi Administration of Traditional Chinese Medicine 2019A106Science and Technology Research Project of Education Department of Jiangxi Province GJJ200143Science and Technology Research Project of Education Department of Jiangxi Province GJJ201210Scientific planning and Planning Fund project of Jiangxi Health Commission 20165401Scientific planning and Planning Fund project of Jiangxi Health Commission 20195637
6 · The paper itself

Abstract

CircRNAs are a member of noncoding RNAs and have been verified to play an important regulatory role in cancers. In CRC, the regulatory mechanisms of various circRNAs have not been elucidated. The expression of circPACRGL and miR-330-3p was detected with qRT-PCR. The protein expression of CDK4, MMP-9, Bcl-2, Bax, cellular nucleic acid-binding protein (CNBP) and β-actin was measured with western blot. Cell proliferation was analyzed using MTT assay, colony formation assay, and EDU assay. Cell apoptosis was detected using flow cytometry. Cell migration and invasion were measured with wound healing and transwell invasion assay. Luciferase reporter assay and RIP assay was used to determine the relationship of among miR-330-3p, circPACRGL and CNBP in CRC cells. In this study, we found that circPACRGL and CNBP expressed high and miR-330-3p expressed low in CRC tissues and cells. Functional experiments showed that inhibition of circPACRGL reduced cell proliferation, migration and invasion in CRC. In addition, knockdown of circPACRGL contributed to cell apoptosis in CRC. Dual-luciferase report assay determined that circPACRGL was a miR-330-3p sponge molecular and CNBP was a target of miR-330-3p. Reversed experiments showed that the effects of sh-circPACRGL transfection on CRC cells were rescued by up-regulating CNBP expression. In this study, we for the first time found a novel regulatory network of circPACRGL in CRC. The results manifested that circPACRGL affected tumor growth by targeting miR-330-3p/CNBP axis in CRC, highlighting the potential of circPACRGL as a therapeutic target for colorectal cancer.

Indexed as

Colorectal NeoplasmsMicroRNAsApoptosisCell Line, TumorCell MovementCell ProliferationHumansRNA-Binding ProteinsRNA, CircularCNBP protein, humanMicroRNAsMIRN330 microRNA, humanRNA-Binding ProteinsRNA, CircularCell progressioncircPACRGLCNBPColorectal cancermiR-330-3p

Identifiers

PMID36459268
OpenAlexW4310603436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.